SecBot SecBot

BKHAR

Black Hawk Acquisition Corp
Nasdaq· Biological Products, (No Diagnostic Substances)· CIK 0002000775 Biotech & Drug Discovery
Rights of Black Hawk Acquisition Corp · BKHA stock page →
—
Short interest
🔒 Subscribers only
New fund stakes
0
Q2 2026 13F · 0 exits

Price

Daily candles with volume.

Signal stack

Where each data set points today.

  • InstitutionsMIXED

    Q2 2026: 0 added (0 new), 2 trimmed or exited.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
TORONTO DOMINION BANKNEAR_EXIT20,000$30.8K
UBS Group AGNEAR_EXIT135$208.00

Quarterly 13F filings are due 45 days after each quarter ends.

Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Aug 17, 2026 Listing status
Listing Status: BKHAR — Normal (was Deficient)
Black Hawk Acquisition Corporation - Rights | Nasdaq Financial Status Indicator D → N
Jun 30, 2026 Inst.
TORONTO DOMINION BANK — NEAR_EXIT
20,000 shares ($30.8K)
Jun 30, 2026 Inst.
UBS Group AG — NEAR_EXIT
135 shares ($208.00)